ArticleFrontiers in oncology2024

Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports.

Yunshuo Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.